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Dear Editor 
 
We thank Pettigrew and colleagues for their letter in response to our 
article 1. They are the team of academic researchers that has been 
funded to undertake an evaluation of the Responsibility Deal (RD). 
Their points of clarification re the funding of their research and its 
current focus are welcome. However, we would have been interested 
to learn whether the findings in our paper will influence their research 
as we feel this might impact on the direction of their research 
evaluation. 
 
The focus of our research was the calorie reduction pledge of the RD, 
and particularly its working practices. We were only examining this one 
aspect of the initiative and we recognise that the research brief of 
Pettigrew et al is much wider.  However, our findings exposed serious 
flaws in both the process and the lack of outcome measures. To reiterate 
the key points in our paper:  Stakeholder representation was seriously compromised with no 
public health representatives on the steering group but a full 
complement of industry representatives.  This stakeholder imbalance enabled the industry lobby to rewrite 
the rules to include processes and Ǯold gainsǯ as indicators of 
success, and to preclude any meaningful monitoring or evaluation 
of industry actions.  Processes became the outcomes on which business were to be 
measured.   There is no agreed outcome measure with respect to population 
level outcomes. In fact, this commitment seems to have been 
written out of the agreement. Industry data on packaged food 
categories could be used to measure a companyǯs commitment to 
a reduction in calories.  
Pettigrew et al point out that the current phase of their research will, 
like our research, evaluate the RD through its working practices. They 
also say they will measure the Ǯimpact of the RD on a range of health and 
nonhealth outcomesǯ, but our point was that the population health and 
nonhealth outcomes had not been agreed at the steering group level. We agree, as we said in the original article, that Ǯit is possible to evaluate the 
potential of Ǯthe Responsibility Deal approachǯ as a public health policy 
tool, by looking in detail at the initiativeǯs working practicesǯ. However in 
the light of our conclusions this comes with serious caveats.  
 
We agree that working practices are an important organisation-level 
component of any evaluation, but this must be combined with the 
evaluation of population-level outcomes. You may evaluate a process but 
if you cannot demonstrate that it is achieving the required, or indeed 
any, contribution to its targets then why continue that evaluation? 
Clearly there is an academic interest in determining what processes 
contribute to the achievement of an outcome. Although we lack the 
insights of Pettigrew and colleagues we feel a question that must be 
posed and addressed is whether there is an evaluative balance between 
process and outcomes. 
 
Our research reinforced the findings of others who have illustrated the 
corporate capture of public health and governmentǯs eagerness to 
implement sanction-free voluntary agreements with business over 
legislative alternatives, to the detriment of public health 2 3. Similar 
criticisms have been levied at other components of the RD, such as the 
alcohol pledge.4 In their paper 5 on how to evaluate a complex initiate 
such as the RD, Pettigrew et al conclude that there is evidence that 
Public Private Partnerships (PPP) can contribute to public health 
outcomes but that business must deliver what it has pledged. Our 
research suggests that business has reneged on its pledge. It has derailed 
the original objective of the initiative which was not just about having 
lower calorie options but was about shifting the whole offering in a 
healthier direction; a goal championed by the then Secretary of State for 
Health.  
 Our findings contend that the delivery of public health outcomes has been compromised. In many respects we feel that industryǯs actions are 
to be expected. They are not there to argue public health at any cost. 
What is disturbing is the lack of a public health voice and the lack of 
accountability by ministers and civil servants to argue for the greater 
good or to set limits on what is negotiable. The corporate capture of public health is epitomised by the RD and governmentǯs eagerness to 
enter into voluntary agreements at the expense of evidence-based 
alternatives that prioritise public health6    
  
The question in our title Ǯbrokering a deal for public health, but on whose 
terms?ǯ still remains valid and has yet to be addressed.  
 
Clare Panjwani 
Martin Caraher 
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